{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/64818403"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "ioid)usually stomachexon 121%some bexon 14<1%unknownexon 186%noneWild Type adult GIST c(no KIT or PDGFRA mutation)10%~66%more with stable disease than with partial response any typeany site* reported as clinical benefit including response or stable disease based on combined data from 3 clinical trials: B2222, EORTC phase I-II, EORTC Phase III.a Rarely gastric GIST can be exon 9." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "gistsupport.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/428736506"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/64818403"] } } }
